This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (2)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Aging/ Geriatrics  • Cardiovascular Disease/ Myocardial Infarction  • Alert me on articles by topic

Role of Brain Natriuretic Peptide, C-Reactive Protein, and Urinary Albumin Levels

Martin Schillinger, MD

JAMA. 2005;293:1667-1669.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Cardiovascular risk prediction by noninvasive laboratory testing in the general population is becoming increasingly recognized as an important health care issue. During the last decade, a variety of novel potentially powerful prognostic biomarkers emerged, which may yield prognostic information even in individuals without evidence of prevalent disease. Among the panel of promising parameters, the role of natriuretic peptides and inflammatory markers has been extensively studied in various populations and clinical settings. Natriuretic peptides have been shown to predict outcome of patients with heart failure, coronary artery, and valvular heart disease.^1-4 However, unlike studies examining C-reactive protein (CRP),^5-7 investigations of natriuretic peptides in predicting future cardiovascular events have not been conducted in population-based samples, and comparative analyses including a variety of prognostic biomarkers are scarce.^{5, 8}

In this issue of JAMA, Kistorp and colleagues⁹ assessed the ability of N-amino terminal fragment of the prohormone brain natriuretic peptide (NT-proBNP) to . . . [Full Text of this Article]

Author Affiliation: Department of Internal Medicine, University of Vienna, Medical School, Vienna, Austria.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

BNP Associated with Cardiovascular Risk
JWatch General 2005;2005:5-5.
FULL TEXT